4.8 Article

Epigenetic Regulation of the DLK1-MEG3 MicroRNA Cluster in Human Type 2 Diabetic Islets

Journal

CELL METABOLISM
Volume 19, Issue 1, Pages 135-145

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2013.11.016

Keywords

-

Funding

  1. NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK070430]
  2. Beckman Research Center/NIDDK/Integrated Islet Distribution Program [10028044]
  3. NIH [U42-RR006042, R01-DK088383, U01-DK089529]
  4. Marilyn Fishman Grant for Diabetes Research from Endocrine Fellows Foundation

Ask authors/readers for more resources

Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the insulin-producing beta cells in the endocrine pancreas to overcome insulin resistance in peripheral tissues. To determine if microRNAs are involved in the pathogenesis of human T2DM, we sequenced the small RNAs of human islets from diabetic and nondiabetic organ donors. We identified a cluster of microRNAs in an imprinted locus on human chromosome 14q32 that is highly and specifically expressed in human beta cells and dramatically downregulated in islets from T2DM organ donors. The downregulation of this locus strongly correlates with hypermethylation of its promoter. Using HITS-CLIP for the essential RISC-component Argonaute, we identified disease-relevant targets of the chromosome 14q32 microRNAs, such as IAPP and TP53INP1, that cause increased beta cell apoptosis upon overexpression in human islets. Our results support a role for microRNAs and their epigenetic control by DNA methylation in the pathogenesis of T2DM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available